Multivariate analysis showed high baseline CMF and AMC were both significantly associated with decreased PFS time.<h4>Conclusion</h4>Baseline CMF and baseline AMC can be potential pan-cancer biomarkers to predict efficacy of PD-1/PD-L1 inhibitors, especially in the PD-L1 subgroup. Here, CD274 is linked to cancer.